CSR Pediatric Renal Nutrition 2 — Questions and Answers

Question 1: Recombinant human growth hormone (rhGH) therapy is sometimes used in children with CKD-related growth failure. Which nutritional PREREQUISITE must be met before initiating rhGH to ensure optimal response?

Serum potassium must be > 5.0 mEq/L before starting rhGH
Adequate nutritional status must be optimized (meeting calorie and protein targets, correcting metabolic acidosis, normalizing CKD-MBD) — as rhGH is ineffective in the presence of severe malnutrition or uncontrolled metabolic derangements (Correct answer)
rhGH can be started at any nutritional status; it overcomes all nutritional deficits
rhGH is only effective in children with normal serum albumin > 4.5 g/dL

Correct answer: Adequate nutritional status must be optimized (meeting calorie and protein targets, correcting metabolic acidosis, normalizing CKD-MBD) — as rhGH is ineffective in the presence of severe malnutrition or uncontrolled metabolic derangements

rhGH requires adequate substrate (energy, protein) to promote protein anabolism and bone formation. Metabolic acidosis blunts the GH-IGF1 axis response, and CKD-MBD impairs bone growth response to rhGH. These must be optimized for rhGH to be effective.

rhGH (somatropin) indications in pediatric CKD: growth failure (height SDS < -1.88) in CKD Stage 2–5 and dialysis; approved by FDA for this indication. Prerequisites for optimal response per KDIGO/KDOQI pediatric guidelines: (1) Nutritional adequacy: energy ≥ 100% DRI, protein ≥ KDOQI recommendation; (2) Metabolic acidosis correction: serum HCO3 ≥ 22 mEq/L (acidosis severely blunts GH-IGF1 axis by increasing protein catabolism and decreasing IGF1 expression); (3) CKD-MBD optimization: PTH within target range, 25-OH-D > 30 ng/mL, adequate calcium; (4) Adequate dialysis (Kt/V ≥ 1.2/session); (5) Absence of uncontrolled hypertension or active malignancy. rhGH dose: 0.05 mg/kg/day SC (CKD) to 0.35 mg/kg/week (SC 6–7 days/week). Expected response: 3–4 cm/year additional height gain above pre-treatment velocity. Monitor: IGF1, glucose (risk of insulin resistance), slipped capital femoral epiphysis (SCFE — rare but serious orthopedic complication).

Question 2: What is the recommended dietary phosphorus intake for a 6-year-old child with CKD Stage 4, compared to the DRI for a healthy 6-year-old?

Same as healthy: 1250 mg/day
Restricted to 80% of DRI: approximately 800–1000 mg/day, to control hyperphosphatemia while ensuring adequate growth and bone mineralization (Correct answer)
No phosphorus restriction at all in children with CKD Stage 4
< 400 mg/day (maximum restriction) to fully prevent all hyperphosphatemia

Correct answer: Restricted to 80% of DRI: approximately 800–1000 mg/day, to control hyperphosphatemia while ensuring adequate growth and bone mineralization

KDOQI pediatric guidelines recommend restricting phosphorus to approximately 80% of DRI (approximately 800–1000 mg/day for a 6-year-old) to control hyperphosphatemia while ensuring adequate phosphorus for bone mineralization and growth — avoiding both excess and deficiency.

DRI for phosphorus: 1–3 years: 460 mg/day; 4–8 years: 500 mg/day; 9–18 years: 1250 mg/day. In CKD Stage 4–5: hyperphosphatemia management must balance phosphorus restriction against growth requirements. KDOQI pediatric recommendation: limit dietary phosphorus to 80% of DRI — for a 6-year-old: 500 × 0.8 = 400 mg/day seems very restrictive (clinical judgment adjusts based on actual serum P). In practice, mild-to-moderate restriction (800–1000 mg/day for the general 6–10 year age group) with phosphate binders at meals is preferred to excessive restriction that could impair bone growth. Unlike adults where phosphorus restriction is more aggressive, children's need for phosphorus in bone mineralization necessitates a less restrictive approach with concurrent binder use rather than severe dietary elimination. Regular serum phosphorus monitoring and individualized adjustment.

Question 3: A 15-year-old adolescent on hemodialysis presents with poor dietary adherence. Which counseling strategy is MOST appropriate given adolescent developmental psychology?

Involve only parents in all dietary discussions to ensure compliance
Use a shared decision-making approach with the adolescent as the primary partner, acknowledge their developmental need for autonomy, identify peer-related dietary challenges (school lunch, social eating), and set collaborative realistic goals (Correct answer)
Threaten serious medical consequences to motivate strict adherence
Remove all dietary decision-making responsibility from the adolescent

Correct answer: Use a shared decision-making approach with the adolescent as the primary partner, acknowledge their developmental need for autonomy, identify peer-related dietary challenges (school lunch, social eating), and set collaborative realistic goals

Adolescents are in a developmental stage where autonomy, peer relationships, and identity formation are paramount. Excluding them from their own care alienates them and worsens adherence. Shared decision-making that respects their growing autonomy while providing education and support produces the best adherence outcomes.

Adolescent-specific counseling in renal dietetics: Developmental stage: Erikson's Identity vs. Role Confusion (ages 12–18) — adolescents prioritize peer acceptance, independence, and identity. CKD in adolescents creates: disrupted peer relationships (dialysis scheduling conflicts with social activities), body image issues (fistulas, growth retardation, steroid-related weight changes), rebellious non-adherence as an expression of autonomy. Evidence-based strategies: (1) Direct communication with the adolescent (not parents first) — they are the primary partner; (2) Motivational interviewing: explore ambivalence about adherence (acknowledge: 'It must be hard to follow these restrictions when your friends eat differently'); (3) Peer-contextualized problem-solving: school lunch options, restaurant strategies, sports event hydration; (4) Short-term, achievable goals set BY the adolescent; (5) Involve parents strategically without undermining adolescent ownership; (6) Technology: apps for food tracking, text reminders (adolescents prefer digital communication); (7) Transition planning: prepare for adult nephrology care by age 14–15.

Question 4: In a premature infant (32 weeks gestation) with congenital renal anomalies requiring early dialysis, which feeding consideration is HIGHEST priority?

Immediate introduction of solid foods to ensure adequate protein intake
Providing human breast milk (or preterm formula) as the primary nutrition source — optimized with human milk fortifier if needed — via gavage feeding, supporting brain development, immune function, and gut maturation (Correct answer)
High-volume formula feeds using adult renal formula
Restricting all fluid to < 30 mL/kg/day regardless of nutritional needs

Correct answer: Providing human breast milk (or preterm formula) as the primary nutrition source — optimized with human milk fortifier if needed — via gavage feeding, supporting brain development, immune function, and gut maturation

Human breast milk is the gold standard for premature infants. It provides optimal protein, immune factors, growth factors, and neurotrophic factors for brain development. In premature CKD infants requiring dialysis, breast milk via gavage with fortification (for extra calories/protein) is the highest priority feeding strategy.

Premature infants (< 34 weeks) require gavage feeding (NG or OG tube) as suck-swallow-breathe coordination is not yet mature. Human breast milk advantages for premature infants: secretory IgA (protects immature gut against NEC), lactoferrin (antimicrobial, anti-inflammatory), growth factors (EGF, IGF1 — gut maturation), long-chain polyunsaturated fatty acids (DHA, ARA — critical for brain development), and prebiotic oligosaccharides (microbiome support). For premature infants on dialysis: fluid restriction (PD or HD removes fluid), requiring caloric concentration of feedings (72–80 kcal/oz vs. standard 20 kcal/oz). Human milk fortifiers (HMF) add protein, calcium, phosphorus, and calories to breast milk — essential in very premature infants. Monitor electrolytes carefully as breast milk phosphorus/potassium may need modification in dialysis. Kangaroo care and oral stimulation support transition to oral feeding. Nutritional adequacy: target weight gain ~15 g/kg/day in premature infants.

Question 5: Iron deficiency is common in pediatric CKD patients on erythropoiesis-stimulating agents (ESAs). What is the preferred route of iron supplementation in a child on hemodialysis?

High-dose oral ferrous sulfate (200 mg elemental iron/day)
Intravenous iron sucrose or ferric gluconate administered during hemodialysis sessions, as oral iron has poor absorption and GI side effects in dialysis patients (Correct answer)
No iron supplementation — rely on dietary iron alone
Intramuscular iron injection monthly

Correct answer: Intravenous iron sucrose or ferric gluconate administered during hemodialysis sessions, as oral iron has poor absorption and GI side effects in dialysis patients

IV iron (iron sucrose, ferric gluconate) administered during HD sessions provides reliable, predictable iron delivery without GI side effects. Oral iron absorption is impaired by uremia, inflammation, phosphate binders (calcium and non-calcium binders reduce iron absorption), and GI side effects limit adherence in children.

Iron management in pediatric HD: Iron deficiency (ferritin < 100 ng/mL, TSAT < 20%) limits ESA response and worsens anemia. Oral iron in HD patients: absorption impaired by (1) Uremia-related hepcidin elevation (blocks intestinal iron absorption), (2) Concurrent phosphate binder administration (calcium carbonate binds iron), (3) GI side effects (constipation, nausea, dark stools) — problematic in children. IV iron in pediatric HD: iron sucrose (Venofer) 1–4 mg/kg per session, maximum 100 mg/dose; ferric gluconate (Ferrlecit) similar dosing. Administered during the last 60–120 minutes of HD. Monitoring: ferritin, TSAT, hemoglobin every 1–3 months; target ferritin 200–500 ng/mL, TSAT 20–40% in pediatric ESA-treated patients. Children transitioning from HD to transplant: pre-transplant iron repletion optimizes post-transplant hemoglobin recovery.

Question 6: In a child with nephrotic syndrome and severe hypoalbuminemia (albumin 1.8 g/dL), which dietary approach to protein intake is currently recommended?

High protein intake (4–5 g/kg/day) to replace urinary losses and normalize albumin
Moderate protein intake matching DRI for age (0.8–1.5 g/kg/day depending on age), as high protein does not replete albumin but increases proteinuria and glomerular damage (Correct answer)
Very-low-protein diet (0.3 g/kg/day) to reduce renal protein load
Protein intake is irrelevant as albumin will normalize with steroids alone

Correct answer: Moderate protein intake matching DRI for age (0.8–1.5 g/kg/day depending on age), as high protein does not replete albumin but increases proteinuria and glomerular damage

In nephrotic syndrome, high protein intake does not effectively raise albumin because increased intake is matched by proportionally increased urinary protein losses (increased proteinuria), while worsening glomerular hyperfiltration. Normal DRI-based protein intake with adequate energy is recommended.

Nephrotic syndrome dietary protein controversy: The traditional recommendation of high protein (2–4 g/kg/day) to replace urinary losses has been disproved. Studies show: high protein intake increases GFR and glomerular filtration pressure → proportional increase in proteinuria, negating any albumin-raising benefit and accelerating glomerular injury. Current evidence (KDIGO 2021, IPNA guidelines): protein intake at or slightly above DRI for age (infants: 1.5 g/kg/day; toddlers: 1.2 g/kg/day; school-age: 0.8–1.0 g/kg/day). Adequate energy is critical for protein-sparing. Sodium restriction (1–2 mEq/kg/day for active edema management). Resolution of nephrotic syndrome with steroid therapy (complete remission in ~95% of children with minimal change disease) normalizes albumin more effectively than dietary protein manipulation. Dietitian role: ensure adequate energy and DRI-appropriate protein; avoid both deficiency and excess protein.

CSR Pediatric Renal Nutrition 2

Recombinant human growth hormone (rhGH) therapy is sometimes used in children with CKD-related growth failure.
Which nutritional PREREQUISITE must be met before initiating rhGH to ensure optimal response?